Home Tags Ecstasy
Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses
There's been a resurgence of interest in psychedelic drugs' potential to treat conditions like depression. Research is beginning to lead to new treatments.
A small new study has shown how MDMA could help reduce social anxiety in people with autism. The study adds to a growing body of research on how drugs such as MDMA can help with anxiety disorders. Microdosing with other drugs like LSD and ketamine has also shown positive results.
Two people are in hospital after taking drugs police are calling 'Snapchat pills.' Dangerous substances are sometimes included in ecstasy pills and pressed into shapes resembling famous logos or brands.
Psychedelic drugs appear to fundamentally reorganize the brain — and they’re starting to turn into approved treatments
From magic mushrooms to ketamine, the drugs are being tested for their potential to treat an array of diseases and conditions that currently lack adequate treatments.
MDMA can help people who suffer from PTSD, according to new research — and it could be approved by 2021
MDMA, the main chemical in ecstasy pills, could help reduce the symptoms of post-traumatic stress disorder, a new study suggests — and researchers are hopeful another trial could mean FDA approval by 2021.
What ‘Molly’ — the Silicon Valley elite’s drug of choice at sex parties — does to your brain and body
Here's what we know about what MDMA, known as Molly or Ecstasy, does to your body and brain.
A non-profit research organization has won a special distinction from the US FDA to speed its study of MDMA, or ecstasy, for medical use to treat PTSD.
Ecstasy, LSD, and magic mushrooms are frequently portrayed as "recreational" or party drugs. This isn't always accurate, according to researchers.
MDMA really might be an incredibly effective therapeutic drug. Trials have been promising enough so far that the FDA has agreed to let one key final test begin.
Rick Doblin wants the drug to be used for psychedelic-assisted psychotherapy in six years.